Steps toward clinical validation of exhaled volatile organic compound biomarkers for hypoglycemia in persons with type 1 diabetes
Abstract Persons with type 1 diabetes (T1D) must track/control their blood glucose (BG) levels to avoid hypoglycemic events (BG < 70 mg/dL), which in the most severe cases can lead to seizures or even death. Canines may lead the way toward innovative testing solutions, as they can be trained to i...
Saved in:
| Main Authors: | Mark Woollam, Paula Angarita-Rivera, Sanskar Thakur, Ali Daneshkhah, Amanda P. Siegel, Dana S. Hardin, Mangilal Agarwal |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-05-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-025-00284-z |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Exhaled volatile organic compounds in the detection of colorectal cancer
by: Daniah Alsaadi, et al.
Published: (2024-05-01) -
Association of exhaled breath volatile organic compounds with surgical traumatic stress
by: Qifeng Wang, et al.
Published: (2025-05-01) -
Electronic Nose Analysis of Exhaled Breath Volatile Organic Compound Profiles during Normoxia, Hypoxia, and Hyperoxia
by: Pasquale Tondo, et al.
Published: (2024-09-01) -
Volatile organic compounds in exhaled human breath for the diagnosis of malignant pleural mesothelioma: a meta-analysis
by: Tingting Zhao, et al.
Published: (2025-05-01) -
Exhaled breath condensate magnesium levels of infants with bronchiolitis
by: Fatma Gül Demirkan, et al.
Published: (2018-10-01)